VWA5A Polyclonal Antibody

Uniprot: O00534
    • polyclonal antibody-Elabscience
    • polyclonal antibody-Elabscience
    • polyclonal antibody-Elabscience
    <
    >
    • polyclonal antibody-Elabscience
    • polyclonal antibody-Elabscience
    • polyclonal antibody-Elabscience
    • polyclonal antibody-Elabscience
    • polyclonal antibody-Elabscience
    • polyclonal antibody-Elabscience

      Catalog number:E-AB-30645

      Synonyms:VWA5A,BCSC1,LOH11CR2A,von Willebrand factor A domain-containing protein 5A,Breast cancer suppressor candidate 1,BCSC-1,Loss of heterozygosity 11 chromosomal region 2 gene A protein

      Size:
      • 20μL
      • 60μL
      • 120μL
      • 200μL
      Qty:
      - +
      Price: $69

      Host: Rabbit

      Reactivity: H

      Applications: WB,ELISA

      Lead Time: 7~10 daysWelcome to order from local distributors.

      Add to cart Compare Bulk request Manual

      Overview

      Synonyms VWA5A,BCSC1,LOH11CR2A,von Willebrand factor A domain-containing protein 5A,Breast cancer suppressor candidate 1,BCSC-1,Loss of heterozygosity 11 chromosomal region 2 gene A protein
      Swissprot O00534
      Source Rabbit
      Reactivity Human
      Immunogen Synthesized peptide derived from the Internal region of human BCSC-1
      Application WB,ELISA
      Recommended dilution WB 1:500-1:2000, ELISA 1:20000
      Concentration 1mg/mL
      Clonality Polyclonal

      Properties

      Cellular localization Nucleus
      Tissue specificity Expressed at low level in many tissues. Not expressed in 80% of tumor cell lines tested.
      Isotype IgG
      Purification Affinity purification
      Storage instructions Store at -20℃. Avoid freeze / thaw cycles.
      Storage buffer PBS with 0.02% sodium azide,0.5% BSA and 50% glycerol pH 7.4.
      Background VWA5A (von Willebrand factor A domain containing 5A), also known as BCSC-1 (breast cancer suppressor candidate 1) or LOH11CR2A (loss of heterozygosity 11 chromosomal region 2 gene A protein), is a 786 amino acid protein containing one VIT domain and one VWFA domain. VWA5A is expressed at low levels in various tissues, with no expression found in 80% of tumor cell lines. Likely acting as a tumor suppressor gene, deletion of VWA5A leads to loss of heterozygosity (LOH) in breast and ovarian tumors, and may have an important role as a potential gene therapy target. Abnormal expression of VWA5A may lead to an increase in adhesion of CNE-2L2 cells associated with an increase in expression of E-cadherin, alpha-catenin, and p53, resulting in a decrease of malignant activity in cells with ectopic expression of VWA5A.

      Images

      Western Blot analysis of 293 cells with VWA5A Polyclonal Antibody

      • Show all (0)
      • Reviews (0)
      • Q&A (0)
      ... Show All Show Less
      嘻嘻嘻

      Browsing History


        People Also Bought